Verquvo

Verquvo is a medicine used to treat adults with long-term heart failure with reduced ejection fraction who recently received treatment given intravenously (into a vein) because their symptoms had worsened. Heart failure with reduced ejection fraction is when the heart does not pump blood as well as it should, especially when the amount of blood being pumped out of the heart is less than the body needs. Some common symptoms of heart failure are shortness of breath, tiredness, or swelling caused by a build-up of fluid. Verquvo contains the active substance vericiguat.